Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

They were talking about *mAbs - *virs combinations with other specific treatments as needed.
Ifenprodil has a good safety and interaction record so "I" think that wont be an issue. Plenty of DD discussed and there are links to lots of interesting stuff on this MB.
Low effectiveness by Rem seems to be the best game in town now and is SOC.

In the NIH videocast the FDA guy stated / stressed the need for complete Data and Trials for FDA considerations of eua-eap-limited use-trials---all approvals, AND completing later stage Trials for all.

...Rem was developed by Gilead in Wuhan China at the Wuhan Virologic inst while researching SArs ect. A theory of initial spread from/in Wuhan is Bat Soup.
Rem already has side affects.
Normal SOC was only improved 15% with Rem. Gilead $ and political pressure to do something seems to have influence on Rem use decisions, IMO.